Sun Pharma CEO on future plans

Though the Rs 1,400-crore (Rs 14 billion)Sun Pharmaceuticals has made substantial investments in R&D over the past five to six years, the corporate decision to convert this intellectual asset into......

Sun Pharma close to US firm buyout

The Dilip Shangvi-promoted Sun Pharmaceutical Industries is close to acquiring the US-based Able Laboratories Inc. Sun Pharma bid for Able Labs following its filing of the US bankruptcy code in......

Mukesh Ambani regains richest Indian slot from Dilip Shanghvi

Reliance Industries chairman Mukesh Ambani is ranked as the richest Indian for eighth consecutive year, although his ranking has come down sharply from among top-ten positions globally earlier.......

No pay, it's all work for these Indian promoters

Around 300 promoters serve their company boards for free. In 1997, Steve Jobs returned to the helm of Apple after a gap of 12 years. For the next 14 years till he retired, he drew an annual salary......